Overview Dividends

(FIGS) Figs - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30260D1037

Medical Scrubs, Apparel

FIGS EPS (Earnings per Share)

EPS Growth (3Y CAGR): 0.00%
EPS Trend (3Y Correlation): -18.2%

FIGS Revenue

Revenue Growth (3Y CAGR): 6.43%
Revenue Trend (3Y Correlation): 30.7%

Description: FIGS Figs

FIGS Inc, listed on the NYSE under the ticker symbol FIGS, operates within the Health Care Supplies sub-industry. As a US-origin company, FIGS has garnered significant attention in the healthcare apparel market, particularly for its scrubs and medical uniforms.

The companys financials indicate a complex picture. With a market capitalization of approximately $1.15 billion, FIGS has demonstrated substantial market presence. However, its price-to-earnings ratio stands at 140.60, suggesting potential overvaluation relative to its earnings. The forward P/E ratio, at 117.65, implies that investors anticipate future earnings growth, albeit with high expectations already priced in. The return on equity (RoE) is relatively low at 1.84%, indicating that the company may not be generating sufficient profits from shareholders equity.

Key economic drivers for FIGS include the growing demand for healthcare services and apparel, driven by an aging population and an increased focus on healthcare infrastructure. The companys performance is also influenced by its ability to innovate and maintain a strong brand presence in a competitive market. Critical KPIs to monitor would include revenue growth, gross margin expansion, and operating expense management, as these will be crucial in determining FIGS ability to improve profitability and justify its current valuation.

From a trading perspective, FIGS stock has shown volatility, with a beta of 1.339 indicating that it is more volatile than the overall market. The stocks recent price action, with a current price of $6.91 and various simple moving averages (SMA20, SMA50, SMA200) below the current price, suggests a positive trend. However, traders should closely monitor the average true range (ATR) and trading volume to gauge market sentiment and potential price movements.

FIGS Stock Overview

Market Cap in USD	1,078m
Sub-Industry	Health Care Supplies
IPO / Inception	2021-05-27

FIGS Stock Ratings

Growth Rating	-25.1%
Fundamental	45.3%
Dividend Rating	-
Return 12m vs S&P 500	10.7%
Analyst Rating	2.90 of 5

FIGS Dividends

Currently no dividends paid

FIGS Growth Ratios

Growth Correlation 3m	91%
Growth Correlation 12m	3.3%
Growth Correlation 5y	-86.7%
CAGR 5y	-10.36%
CAGR/Max DD 3y	-0.16
CAGR/Mean DD 3y	-0.27
Sharpe Ratio 12m	-0.06
Alpha	16.54
Beta	0.887
Volatility	57.04%
Current Volume	1482.9k
Average Volume 20d	1769.9k
Stop Loss	6.7 (-5.4%)
Signal	-0.86

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (7.18m TTM) > 0 and > 6% of Revenue (6% = 34.2m TTM)

FCFTA 0.08 (>2.0%) and ΔFCFTA -7.18pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 55.35% (prev 61.84%; Δ -6.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.10 (>3.0%) and CFO 49.8m > Net Income 7.18m (YES >=105%, WARN >=100%)

Net Debt (846.0k) to EBITDA (18.1m) ratio: 0.05 <= 3.0 (WARN <= 3.5)

Current Ratio 5.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (172.9m) change vs 12m ago -3.76% (target <= -2.0% for YES)

Gross Margin 67.23% (prev 67.38%; Δ -0.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 109.2% (prev 104.7%; Δ 4.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM)

Altman Z'' 5.19

(A) 0.61 = (Total Current Assets 393.6m - Total Current Liabilities 78.4m) / Total Assets 517.1m

(B) 0.14 = Retained Earnings (Balance) 71.5m / Total Assets 517.1m

(D) 0.59 = Book Value of Equity 71.6m / Total Liabilities 120.6m

Total Rating: 5.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 45.28

1. Piotroski 4.0pt = -1.0

2. FCF Yield 4.48% = 2.24

3. FCF Margin 7.00% = 1.75

4. Debt/Equity 0.13 = 2.49

5. Debt/Ebitda 2.86 = -1.57

6. ROIC - WACC -8.54% = -10.67

7. RoE 1.84% = 0.15

8. Rev. Trend 30.69% = 1.53

9. Rev. CAGR 6.43% = 0.80

10. EPS Trend -18.24% = -0.46

11. EPS CAGR 0.0% = 0.0

What is the price of FIGS shares?

As of September 15, 2025, the stock is trading at USD 7.08 with a total of 1,482,931 shares traded.
Over the past week, the price has changed by +3.66%, over one month by +3.51%, over three months by +32.83% and over the past year by +30.87%.

Is Figs a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Figs (NYSE:FIGS) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.28 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FIGS is around 6.58 USD . This means that FIGS is currently overvalued and has a potential downside of -7.06%.

Is FIGS a buy, sell or hold?

Figs has received a consensus analysts rating of 2.90. Therefor, it is recommend to hold FIGS.

Strong Buy: 0
Buy: 1
Hold: 7
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the FIGS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	6.4	-9.3%
Analysts Target Price	6.4	-9.3%
ValueRay Target Price	7.4	4.1%

Last update: 2025-09-05 04:42

FIGS Fundamental Data Overview

Market Cap USD = 1.08b (1.08b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 238.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 132.0
P/E Forward = 94.3396
P/S = 1.8919
P/B = 2.7176
Beta = 1.339
Revenue TTM = 569.6m USD
EBIT TTM = 9.21m USD
EBITDA TTM = 18.1m USD
Long Term Debt = 42.2m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 9.55m USD (from shortTermDebt, last quarter)
Debt = 51.8m USD (Calculated: Short Term 9.55m + Long Term 42.2m)
Net Debt = 846.0k USD (from netDebt column, last quarter)
Enterprise Value = 890.5m USD (1.08b + Debt 51.8m - CCE 238.8m)
Interest Coverage Ratio = unknown (Ebit TTM 9.21m / Interest Expense TTM 0.0)
FCF Yield = 4.48% (FCF TTM 39.9m / Enterprise Value 890.5m)
FCF Margin = 7.00% (FCF TTM 39.9m / Revenue TTM 569.6m)
Net Margin = 1.26% (Net Income TTM 7.18m / Revenue TTM 569.6m)
Gross Margin = 67.23% ((Revenue TTM 569.6m - Cost of Revenue TTM 186.7m) / Revenue TTM)
Tobins Q-Ratio = 12.45 (Enterprise Value 890.5m / Book Value Of Equity 71.6m)
Interest Expense / Debt = 15.15% (Interest Expense 7.85m / Debt 51.8m)
Taxrate = 81.03% (11.6m / 14.3m)
NOPAT = 1.75m (EBIT 9.21m * (1 - 81.03%))
Current Ratio = 5.02 (Total Current Assets 393.6m / Total Current Liabilities 78.4m)
Debt / Equity = 0.13 (Debt 51.8m / last Quarter total Stockholder Equity 396.5m)
Debt / EBITDA = 2.86 (Net Debt 846.0k / EBITDA 18.1m)
Debt / FCF = 1.30 (Debt 51.8m / FCF TTM 39.9m)
Total Stockholder Equity = 389.7m (last 4 quarters mean)
RoA = 1.39% (Net Income 7.18m, Total Assets 517.1m )
RoE = 1.84% (Net Income TTM 7.18m / Total Stockholder Equity 389.7m)
RoCE = 2.13% (Ebit 9.21m / (Equity 389.7m + L.T.Debt 42.2m))
RoIC = 0.45% (NOPAT 1.75m / Invested Capital 389.7m)
WACC = 8.99% (E(1.08b)/V(1.13b) * Re(9.28%)) + (D(51.8m)/V(1.13b) * Rd(15.15%) * (1-Tc(0.81)))
Shares Correlation 3-Years: -72.73 | Cagr: -0.71%
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.07% ; FCFE base≈55.3m ; Y1≈36.3m ; Y5≈16.6m
Fair Price DCF = 1.73 (DCF Value 268.3m / Shares Outstanding 155.0m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 30.69 | Revenue CAGR: 6.43%
Rev Growth-of-Growth: 0.09
EPS Correlation: -18.24 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -55.59

Additional Sources for FIGS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle